OPEN Summit 2023 Abstracts–Poster and Oral Presentations

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada Pub Date : 2023-12-18 DOI:10.1177/17151635231219546

Yasmin Abdul Aziz, Vivian Ng, Diya Srinivasan, Julie Vo, Laura Desveaux, Kevin Schwartz, Z. Rosenberg-Yunger, Erin Berenbaum, Lindsay Friedman, Bradley Langford, Valerie Leung, Emily Angl, Nardine Nakhla, Mina Tadrous, Barbara Farrell, Mathew DeMarco, Nancy Waite, Lisa Dolovich, Mansur Mehdi, Jon Jones, Humayra Tasnim, Mhd Wasem, E. Alsabbagh, Kelly Neiterman, Grindrod, Kristy Scarfone, Shaleesa Ledlie, D. Shearer, Tara Gomes

{"title":"OPEN Summit 2023 Abstracts–Poster and Oral Presentations","authors":"Yasmin Abdul Aziz, Vivian Ng, Diya Srinivasan, Julie Vo, Laura Desveaux, Kevin Schwartz, Z. Rosenberg-Yunger, Erin Berenbaum, Lindsay Friedman, Bradley Langford, Valerie Leung, Emily Angl, Nardine Nakhla, Mina Tadrous, Barbara Farrell, Mathew DeMarco, Nancy Waite, Lisa Dolovich, Mansur Mehdi, Jon Jones, Humayra Tasnim, Mhd Wasem, E. Alsabbagh, Kelly Neiterman, Grindrod, Kristy Scarfone, Shaleesa Ledlie, D. Shearer, Tara Gomes","doi":"10.1177/17151635231219546","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Expanding pharmacists' scope of practice to include prescribing for thirteen minor ailments, including infectious diseases, in the community pharmacy setting began January 2023. This expansion presents opportunities to improve patients’ access to timely care and harness pharmacists’ expertise to increase appropriate prescribing. Identifying key facilitators and barriers for the effective implementation of pharmacist prescribing is crucial to proactively support this evolution. OBJECTIVE : To identify facilitators and barriers for the effective implementation of pharmacists prescribing medications for selected minor ailments and infectious diseases METHODS : Virtual interviews and online surveys were utilized to gather pharmacists’ perspectives on service provision across Ontario prior to the launch. Virtual focus group discussions were conducted with primary care physicians and patients separately. Focus groups and interviews were audio recorded, transcribed verbatim and thematically analyzed. Data analysis was guided by the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework","PeriodicalId":9476,"journal":{"name":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","volume":"50 ","pages":"S1 - S45"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17151635231219546","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

BACKGROUND: Expanding pharmacists' scope of practice to include prescribing for thirteen minor ailments, including infectious diseases, in the community pharmacy setting began January 2023. This expansion presents opportunities to improve patients’ access to timely care and harness pharmacists’ expertise to increase appropriate prescribing. Identifying key facilitators and barriers for the effective implementation of pharmacist prescribing is crucial to proactively support this evolution. OBJECTIVE : To identify facilitators and barriers for the effective implementation of pharmacists prescribing medications for selected minor ailments and infectious diseases METHODS : Virtual interviews and online surveys were utilized to gather pharmacists’ perspectives on service provision across Ontario prior to the launch. Virtual focus group discussions were conducted with primary care physicians and patients separately. Focus groups and interviews were audio recorded, transcribed verbatim and thematically analyzed. Data analysis was guided by the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework

查看原文本刊更多论文

2023 年开放峰会摘要--海报和口头报告

背景：从 2023 年 1 月起，药剂师的执业范围将扩大到包括在社区药房开具十三种轻微疾病（包括传染病）的处方。这一扩展为改善患者获得及时护理的机会，以及利用药剂师的专业知识增加适当处方提供了机遇。确定有效实施药剂师处方的关键促进因素和障碍对于积极支持这一演变至关重要。目的：确定有效实施药剂师为特定轻微疾病和传染病开处方的促进因素和障碍方法：采用虚拟访谈和在线调查的方式，收集药剂师对安大略省各地在启动之前所提供服务的看法。分别与初级保健医生和患者进行了虚拟焦点小组讨论。对焦点小组和访谈进行了录音、逐字记录和主题分析。数据分析以实施研究综合框架 (CFIR) 和理论领域框架为指导

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

自引率

0.00%

发文量